Cytokine response to endotoxin in individuals heterozygous for the Δ32 mutation of chemokine receptor CCR5

Cytokine

Volumn 21, Issue 4, 2003, Pages 195-199

  Heesen, Michael ^a   Schippers, Emile F ^b   Bloemeke, Brunhilde ^c   Kunz, Dagmar ^c   Van Dissel, Jaap T ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

CC chemokine receptor 5; Cytokines; Endotoxin; Genetic polymorphism

Indexed keywords

ENDOTOXIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; BLOOD; CONTROLLED STUDY; CYTOKINE RELEASE; EXTRACORPOREAL CIRCULATION; GENE DELETION; GENE MUTATION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOTE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; SURGICAL INJURY; WILD TYPE;

EID: 0037604676     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-4666(02)00497-0     Document Type: Article

References (26)

1. Raport C.J., Gosling J., Schweickart V.L., Gray P.W., Charo I.F. Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1β, and MIP-1α J Biol Chem. 271:1996;17161-17166.
2. Qin S., Rottman J.B., Myers P., Kassam N., Weinblatt M., Loetscher M., et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest. 101:1998;746-754.
3. Dragic T., Litwin V., Allaway G.P., Martin S.R., Huang Y., Nagashima K.A., et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature. 381:1996;667-673.
4. Liu R., Paxton W.A., Choe S., Ceradini D., Martin S.R., Horuk R., et al. Homozygous defect in HIV-1 coreceptor accounts for resistance to some multiply-exposed individuals to HIV-1 infection. Cell. 86:1996;367-377.
5. Huang Y., Paxton W.A., Wolinsky S.M., Neumann A.U., Zhang L., He T., et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med. 2:1996;1240-1243.
6. Rowe P.M. CKR-5 deletion heterozygotes progress slower to AIDS. Lancet. 348:1996;947.
7. Martinson J.J., Chapman N.H., Rees D.C., Liu Y.T., Clegg J.B. Global distribution of the CCR5 gene 32-basepair deletion. Nat Genet. 16:1997;100-103.
8. Zhou Y., Kurihara T., Ryseck R-P, Yang Y., Ryan C., Loy J., et al. Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. J Immunol. 160:1998;4018-4025.
9. Wan S., LeClerc J.L., Vincent J.L. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest. 112:1997;676-692.
10. Wan S., LeClerc J.L., Vincent J.L. Cytokine responses to cardiopulmonary bypass: lessons learned from cardiac transplantation. Ann Thorac Surg. 63:1997;269-276.
11. Bouter H., Schippers E.F., Luelmo S.A., Versteegh M.I., Ros P., Guiot H.F., et al. No effect of preoperative selective gut decontamination on endotoxemia and cytokine activation during cardiopulmonary bypass: a randomized, placebo-controlled study. Crit Care Med. 30:2002;38-43.
12. Sablotzki A., Welters I., Lehmann N., Menges T., Gorlach G., Dehne M., et al. Plasma levels of immunoinhibitory cytokines interleukin-10 and transforming growth factor-beta in patients undergoing coronary artery bypass grafting. Eur J Cardiothorac Surg. 11:1997;763-768.
13. Marti F., Munoz J., Peiro M., Bertran E., Ferran C., Octavio C., et al. Higher cytotoxic activity and increased levels of IL-1 beta, IL-6, and TNF-alpha in patients undergoing cardiopulmonary bypass. Am J Hematol. 49:1995;237-239.
14. Meldrum D.R. Tumor necrosis factor in the heart. Am J Physiol. 274:1998;R577-R595.
15. Heinrich P.C., Castell J.V., Andus T. Interleukin-6 and the acute phase response. Biochem J. 265:1990;621-636.
16. Wan S., LeClerc J-L, Vincent J-L. Cytokine response to cardiopulmonary bypass: lessons learned from cardiac transplantation. Ann Thorac Surg. 63:1997;269-276.
17. Paxton W.A., Martin S.R., Tse D., O'Brien T.R., Skurnick J., VanDevanter N.L., et al. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nat Med. 2:1996;412-417.
18. Yang J.Y., Togni M., Widmer U. Heterozygous defect in HIV-1 coreceptor CCR5 and chemokine production. Cytokine. 11:1999;1-7.
19. Trkola A., Dragic T., Arthos J., Binley J.M., Olson W.C., Allaway G.P., et al. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature. 384:1996;184-187.
20. Wu L., Paxton W.A., Kassam N., Ruffing N., Rottman J.B., Sullivan N., et al. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med. 185:1997;1681-1691.
21. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA. 94:1997;3195-3199.
22. El-Omar E.M., Carrington M., Chow W-H, McColl K.E., Bream J.H., Young H.A., et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 404:2000;398-402.
23. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 102:1997;1369-1376.
24. Eskdale J., Gallagher G., Verweij C.L., Keijsers V., Westendorp R.G., Huizinga T.W. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA. 95:1998;9465-9470.
25. De Groote D., Zangerle P.F., Gevaert Y., Fassotte M.F., Beguin Y., Noizat-Pirenne F., et al. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood I. Comparison with isolated PBMC stimulation. Cytokine. 4:1992;239-248.
26. van Dissel J.T., van Langevelde P., Westendorp R.G., Kwappenberg K., Frolich M. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet. 351:1998;950-953.